Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Astrana Updates 2025 Guidance After Prospect Health Deal; Sees $3.1B–$3.3B Revenue, $215M–$225M EBITDA, Targets $12M–$15M Synergies

Author: Benzinga Newsdesk | July 02, 2025 06:06am

Posted In: ASTH